A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China.
OBJECTIVE
To assess knowledge of HPV and attitudes towards HPV vaccination among the general female population, government officials, and healthcare providers in China to assist the development of an effective national HPV vaccination program.


METHODS
A cross-sectional epidemiologic survey was conducted across 21 urban and rural sites in China using a short questionnaire. 763 government officials, 760 healthcare providers, and 11,681 women aged 15-59 years were included in the final analysis. Data were analyzed using standard descriptive statistics and logistic regression.


RESULTS
Knowledge of HPV among the general female population was low; only 24% had heard of HPV. Less than 20% of healthcare providers recognized sexually naive women as the most appropriate population for HPV vaccination. There was high acceptance of the HPV vaccine for all categories of respondents. Only 6% of women were willing to pay more than US $300 for the vaccine.


CONCLUSIONS
Aggressive education is necessary to increase knowledge of HPV and its vaccine. Further proof of vaccine safety and efficacy and government subsidies combined with increased awareness could facilitate development and implementation of HPV vaccination in China.
Department of Epidemiology, Cancer Institute of Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Gynaecology and Obstetrics, Beijing Tongren Hospital, Beijing, China.
Fang-Hui
FH
Zhao
Sarah M
SM
Tiggelaar
Shang-Ying
SY
Hu
Na
N
Zhao
Ying
Y
Hong
Mayinuer
M
Niyazi
Xiao-Hong
XH
Gao
Li-Rong
LR
Ju
Li-Qin
LQ
Zhang
Xiang-Xian
XX
Feng
Xian-Zhi
XZ
Duan
Xiu-Ling
XL
Song
Jing
J
Wang
Yun
Y
Yang
Chang-Qin
CQ
Li
Jia-Hua
JH
Liu
Ji-Hong
JH
Liu
Yu-Bo
YB
Lu
Li
L
Li
Qi
Q
Zhou
Jin-Feng
JF
Liu
Li-Na
LN
Xu
You-Lin
YL
Qiao
D000288:Administrative Personnel / Q000706:statistics & numerical data*; D000293:Adolescent; D000328:Adult; D001294:Attitude to Health; D002681:China / Q000453:epidemiology; D003430:Cross-Sectional Studies; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006282:Health Personnel / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D027383:Papillomaviridae / Q000472:pathogenicity; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D011379:Prognosis; D011795:Surveys and Questionnaires; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination; D016387:Women's Health; D055815:Young Adult
D053918:Papillomavirus Vaccines